Related Experiment Videos
Graft rejection across transgene-encoded MHC class II molecules
P Rosay1, J Hergueux, C Benoist
1Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS et INSERM U. 184, Institut de Chimie Biologique, Strasbourg, France.
Summary
Major histocompatibility complex class II molecules can trigger allograft rejection, with specific molecules like A alpha and A beta being potent inducers. Tolerance requires matching both chains of the target class II heterodimers.
Area of Science:
- Immunology
- Transplantation immunology
- Molecular genetics
Background:
- The major histocompatibility complex (MHC) plays a critical role in the immune response.
- Class II MHC molecules are key players in immune recognition and graft rejection.
Purpose of the Study:
- To evaluate the potential of class II MHC gene products as targets for allograft rejection.
- To understand the role of individual class II molecules and their chains in graft rejection and tolerance.
Main Methods:
- Utilized transgenic mouse lines expressing specific class II MHC genes on a common genetic background.
- Assessed graft rejection and tolerance induction by testing single class II molecules or single chains of class II heterodimers.
Main Results:
- Demonstrated that certain class II molecules, specifically A alpha and A beta, induce highly efficient allograft rejection.
- Showed that other class II molecules, such as E, are relatively ineffective in rejection.
- Found that tolerance induction necessitates matching for both alpha and beta chains of the target class II heterodimers.
Conclusions:
- Class II MHC molecules exhibit variable capacity to induce allograft rejection.
- Both chains of a class II heterodimer are crucial for inducing immune tolerance.